medigraphic.com
SPANISH

Revista Mexicana de Angiología

Órgano Oficial de la Sociedad Mexicana de Angiología y Cirugía Vascular
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 2

<< Back

Rev Mex Angiol 2015; 43 (2)

Disfunción endotelial y debut trombótico arterial en enfermedades reumatológicas. A propósito de dos casos

Santillán-Aguayo E, Córdova-Quintal P, Carbajal-Robles V, Lecuona-Huet NE, Campero-Urcullo A
Full text How to cite this article

Language: Spanish
References: 10
Page: 81-84
PDF size: 335.45 Kb.


Key words:

Chronic inflammatory autoimmune disease, polyarteritis nodosa, Antiphospholipid syndrome.

ABSTRACT

Introduction. Chronic inflammatory autoimmune diseases are a heterogeneous group in which endothelial dysfunction has as its ultimate expression increased cardiovascular risk due to accelerated atherosclerosis.
Objective. Describe two cases of chronic inflammatory autoimmune diseases with arterial complications as disease onset.
Case report. We present two cases of patients with secondary arterial thrombotic debut with endothelial dysfunction inherit to polyarteritis nodosa and antiphospholipid syndrome confirmed by biopsy.
Conclusions. Endothelial dysfunction, cardiovascular risk factors and complications arising from the physiological and hemodynamic implications have been extensively studied, however, focused on coronary artery disease; so, establishing an association to peripheral artery disease will broaden the panorama of study and treatment in this type of patients to reduce long term complications caused by late detection.


REFERENCES

  1. Steyers CM, Miller FJ. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci 2014; 15; 11324- 11349; doi:10.3390/ijms150711324.

  2. Freire da Silva F, Abramino Levy R, Freire de Carvalho J. Cardiovascular risk factors in the Antiphospholipid syndrome. J Immunology Research 2014; 2014: 1-6.

  3. Murdaca G, Colombo BM, Cagnati P, Gulli R, Spano F, Puppo F. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis 2012; 224: 309-17.

  4. Prati C, Demougeot C, Guillot X, Godfrin-Valnet M, Wending D. Endothelial dysfunction in joint disease. Jt. Bone Spine 2014; doi:10.1016/j.jbspin.2014.01.014.

  5. Soltész P, Dér H, Kerekes G, Szodoray P, Szücs G, Dankó K, Shoenfeld Y, et al. A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases. Clin Rheumatol 2009; 28(6): 655-62.

  6. Davignon J, Ganz P. Role of endothelial dysfunction in Atherosclerosis. Circulation 2009; 109(III): 27-32.

  7. Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa. Arth & Rheuma 2010; 62(2): 616-26.

  8. Sharma S, Kumar S, Mishra NK, Gaikwad SB. Cerebral miliary micro aneurysms in polyarteritis nodosa: report of two cases. Neurol India 2010; 58(3): 457-9.

  9. Bonsib SM. Polyarteritis nodosa. Semin Diagn Pathol 2001; 18(1): 14-23.

  10. Atanassova P. Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview. Yonsei Med J 2007; 48(6): 901-26.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Angiol. 2015;43